Niclosamide as a potential antivirulence agent disrupting quorum sensing in Pseudomonas aeruginosa: A molecular and

Malik Suliman Mohamed1, Raya Soltane2, Eid Alatwi3

  • 1Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, 72388, Al-Jouf, Kingdom of Saudi Arabia.

Insights

Niclosamide (NIC) effectively reduces virulence in Pseudomonas aeruginosa by disrupting its quorum sensing (QS) system. This antivirulence agent inhibits biofilm formation and key toxins, making the pathogen less harmful.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Discovery

Background:

  • Pseudomonas aeruginosa is a significant pathogen causing difficult infections.
  • Quorum sensing (QS) controls P. aeruginosa virulence factors.
  • Targeting QS is a promising antivirulence strategy.

Purpose of the Study:

  • To investigate niclosamide (NIC) as an antivirulence agent against P. aeruginosa.
  • To evaluate NIC's impact on biofilm formation and pigment production.
  • To determine NIC's molecular interaction with the LasR QS regulator.

Main Methods:

  • In-silico, molecular, and in vitro analyses were performed.
  • Sub-inhibitory NIC concentrations (64 μg/ml) were tested.
  • Assays included biofilm inhibition, pigment production measurement, LasR interaction studies, molecular modeling, MD simulations, sedimentation velocity, and thermal shift assays.

Main Results:

  • NIC significantly reduced biofilm formation (45.4%), pyocyanin (48.8%), and rhamnolipid (41.3%) production.
  • NIC acted as a dose-dependent antagonist of LasR (IC50 = 5.82 μM) without agonistic effects.
  • Molecular dynamics and experimental assays confirmed NIC's interaction with LasR, inhibiting dimerization and destabilizing its structure.

Conclusions:

  • Niclosamide is a promising antivirulence agent against P. aeruginosa.
  • NIC disrupts the LasR-mediated QS system, reducing virulence.
  • NIC enhances susceptibility to antibiotics and immune responses by inhibiting key virulence factors.